Product Information

OLMESARTAN MEDOXOMIL 20 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0810 per EA under NDC 82009007490. Its NADAC has been published 136 times since Jan 17, 2024.

FDA first approved this application on Apr 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN MEDOXOMIL 20 MG TAB

Olmesartan Medoxomil
$0.0810per EA

Strength

20 mg/1

NDC

82009007490

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

Generic (ANDA)

FDA Application

ANDA204798

FDA Approved

4/24/2017

TE Code

AB

On Market Since

8/1/2023

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has been published 136 times since Jan 17, 2024, and over the history we have for it it has declined 3.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0810 per EA
All-time high$0.0925 (Apr 10, 2024)
All-time low$0.0705 (Nov 20, 2024)
52-week high$0.0825
52-week low$0.0732
Median price$0.0813
Average price$0.0805
Largest weekly change-20.3% (Nov 20, 2024)
Weeks tracked136
Tracking sinceJan 17, 2024

Price History

1W

-0.3%

1M

-0.3%

3M

+4.0%

6M

+10.8%

1Y

-1.8%

3Y

N/A

5Y

N/A

All

-3.3%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLMESARTAN MEDOXOMIL 20 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 20 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0810 per EA (NDC 82009007490), effective Aug 19, 2026.

How has the price of OLMESARTAN MEDOXOMIL 20 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has declined 3.3%. It has been tracked across 136 weekly CMS publications since Jan 17, 2024.

What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 20 MG TAB?

Since Jan 17, 2024, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has ranged from a low of $0.0705 (Nov 20, 2024) to a high of $0.0925 (Apr 10, 2024), with a median of $0.0813 per EA.

Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 20 MG TAB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 20 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMESARTAN MEDOXOMIL 20 MG TAB?

OLMESARTAN MEDOXOMIL 20 MG TAB (NDC 82009007490) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.